Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue

Authors:

Abstract
The kinetics of marrow engraftment were analyzed in 50 patient with acute leukemia (21), malignant lymphoma (15), and solid tumors (14) after high-dose multiagent chemotherapy followed by autologous bone marrow transplantation (ABMT) with nonfrozen bone marrow. Unseparated heparinized whole bone marrow was stored in 10% CPDA1 at 4°C for 72 h, then filtered and reinfused. The median number of nucleated cells reinfused was 1.6×108/kg (range 0.5–3.8×108/kg). All patients had a full hematopoietic reconstitution. Median time to achieve a neutrophil count > 500/μl was 20 days (range 12–39) and median time to achieve an unsupported platelet count > 20.000/μl was 20 days (range 10–55). The main factor associated with delayed engraftment was the number of prior chemotherapy cycles. We conclude that high-dose chemotherapy with nonfrozen ABMT is a safe procedure, without the requirement for costly cryopreservation facilities.

This publication has 27 references indexed in Scilit: